233 related articles for article (PubMed ID: 28733489)
1. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders.
Abramov AY; Berezhnov AV; Fedotova EI; Zinchenko VP; Dolgacheva LP
Biochem Soc Trans; 2017 Aug; 45(4):1025-1033. PubMed ID: 28733489
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration.
Abramov AY; Potapova EV; Dremin VV; Dunaev AV
Life (Basel); 2020 Jun; 10(7):. PubMed ID: 32629809
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein and beta-amyloid - different targets, same players: calcium, free radicals and mitochondria in the mechanism of neurodegeneration.
Angelova PR; Abramov AY
Biochem Biophys Res Commun; 2017 Feb; 483(4):1110-1115. PubMed ID: 27470584
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.
Briston T; Hicks AR
Biochem Soc Trans; 2018 Aug; 46(4):829-842. PubMed ID: 29986938
[TBL] [Abstract][Full Text] [Related]
5. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols.
Camilleri A; Zarb C; Caruana M; Ostermeier U; Ghio S; Högen T; Schmidt F; Giese A; Vassallo N
Biochim Biophys Acta; 2013 Nov; 1828(11):2532-43. PubMed ID: 23817009
[TBL] [Abstract][Full Text] [Related]
7. The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates.
Moretto E; Stuart S; Surana S; Vargas JNS; Schiavo G
Front Cell Neurosci; 2022; 16():844211. PubMed ID: 35573838
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases.
Alexiou A; Nizami B; Khan FI; Soursou G; Vairaktarakis C; Chatzichronis S; Tsiamis V; Manztavinos V; Yarla NS; Md Ashraf G
Curr Protein Pept Sci; 2018; 19(9):850-857. PubMed ID: 28799502
[TBL] [Abstract][Full Text] [Related]
9. Retinol (Vitamin A) Increases α-Synuclein, β-Amyloid Peptide, Tau Phosphorylation and RAGE Content in Human SH-SY5Y Neuronal Cell Line.
Kunzler A; Kolling EA; da Silva JD; Gasparotto J; de Bittencourt Pasquali MA; Moreira JCF; Gelain DP
Neurochem Res; 2017 Oct; 42(10):2788-2797. PubMed ID: 28497345
[TBL] [Abstract][Full Text] [Related]
10. Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?
Windisch M; Wolf HJ; Hutter-Paier B; Hofmeister A; Wronski R
Curr Alzheimer Res; 2007 Sep; 4(4):446-57. PubMed ID: 17908049
[TBL] [Abstract][Full Text] [Related]
11. Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase.
Ludtmann MH; Angelova PR; Ninkina NN; Gandhi S; Buchman VL; Abramov AY
J Neurosci; 2016 Oct; 36(41):10510-10521. PubMed ID: 27733604
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Ca
Naia L; Ferreira IL; Ferreiro E; Rego AC
Biochem Biophys Res Commun; 2017 Feb; 483(4):1069-1077. PubMed ID: 27485547
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
14. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
Arawaka S; Machiya Y; Kato T
Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
[TBL] [Abstract][Full Text] [Related]
15. Influence of physical exercise on β-amyloid, α-synuclein and tau accumulation: an in vitro model of oxidative stress in human red blood cells.
Iofrida C; Daniele S; Pietrobono D; Fusi J; Galetta F; Trincavelli ML; Bonuccelli U; Franzoni F; Martini C
Arch Ital Biol; 2017 Jul; 155(1-2):33-42. PubMed ID: 28715596
[TBL] [Abstract][Full Text] [Related]
16. Development or disease: duality of the mitochondrial permeability transition pore.
Pérez MJ; Quintanilla RA
Dev Biol; 2017 Jun; 426(1):1-7. PubMed ID: 28457864
[TBL] [Abstract][Full Text] [Related]
17. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant modulation in restoring mitochondrial function in neurodegeneration.
Pahrudin Arrozi A; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
Int J Neurosci; 2017 Mar; 127(3):218-235. PubMed ID: 27074540
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
20. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
Lee SJ
Antioxid Redox Signal; 2003 Jun; 5(3):337-48. PubMed ID: 12880487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
